American Journal of Kidney Diseases
Volume 57, Issue 2 , Pages 255-265 , February 2011

Hemoglobin Variability and Mortality: Confounding by Disease Severity

  • Eric D. Weinhandl, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • Corresponding Author InformationAddress correspondence to Eric D. Weinhandl, MS, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th St, Ste S-206, Minneapolis, MN 55404
    • ,
  • Yi Peng, MS

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • David T. Gilbertson, PhD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • ,
  • Brian D. Bradbury, MA, DSc

      Affiliations

    • Department of Biostatistics and Epidemiology, Amgen Inc, Thousand Oaks, CA
    • ,
  • Allan J. Collins, MD

      Affiliations

    • Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN
    • Hennepin County Medical Center, Minneapolis, MN
    • University of Minnesota, Minneapolis, MN

Received 19 January 2010 ,Accepted 7 June 2010.

References 

  1. Lacson E, Ofsthun N, Lazarus JM. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis. 2003;41:111–124
  2. Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, DeOreo PB. Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int. 2003;64:1514–1521
  3. Fishbane S, Berns JS. Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int. 2005;68:1337–1343
  4. Ebben JP, Gilbertson DT, Foley RN, Collins AJ. Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol. 2006;1:1205–1210
  5. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI. Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol. 2007;18:3164–3170
  6. Brunelli SM, Lynch KE, Ankers ED, et al. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:1733–1740
  7. Fishbane S, Berns JS. Evidence and implications of haemoglobin cycling in anaemia management. Nephrol Dial Transplant. 2007;22:2129–2132
  8. Brunelli SM, Joffe MM, Israni RK, et al. History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:777–782
  9. Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol. 2008;3:133–138
  10. Ishani A, Solid CA, Weinhandl ED, Gilbertson DT, Foley RN, Collins AJ. Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death. Nephrol Dial Transplant. 2008;23:1682–1689
  11. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;
  12. Patel T, Hirter A, Kaufman J, Keithi-Reddy SR, Reda D, Singh A. Route of epoetin administration influences hemoglobin variability in hemodialysis patients. Am J Nephrol. 2009;29:532–537
  13. Germain MJ, Ho W, Garb J, Bartlett C, Will E. A prospective case-controlled study of the effect of continuous hemoglobin variability in hemodialysis patients [abstract]. Am J Kidney Dis. 2008;51(4):A48
  14. Terrell G, Scott D. Oversmoothed nonparametric density estimates. J Am Stat Assoc. 1985;80:209–214
  15. DeFrancisco AL, Macdougall IC, Carrera F, et al. Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients. Clin Nephrol. 2009;71:397–404
  16. Solid CA, Foley RN, Gilbertson DT, Collins AJ. Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003. Hemodial Int. 2007;11:442–447
  17. Brophy D, Harley C, Chastek B, et al. Inpatient use of erythropoiesis stimulating agents among commercially-insured dialysis patients [abstract]. Am J Kidney Dis. 2008;51(4):B37
  18. Fischer MA, Morris CA, Winkelmayer WC, Avorn J. Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients. Arch Intern Med. 2007;167:840–846
  19. Kazmierczak E, Sobieska M, Kazmierczak M, Mrozikiewicz A, Wiktorowicz K. Intense acute phase response in ischemic patients. Int J Cardiol. 1999;68:69–73
  20. Nassar GM, Fishbane S, Ayus JC. Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients. Kidney Int Suppl. 2002;80:49–54
  21. Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int. 2004;66:2429–2436
  22. Macdougall IC, Cooper AC. Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2002;179(suppl 11):39–43
  23. Nissenson AR, Dylan ML, Griffiths RI, Yu HT, Dubois RW. Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin. Clin J Am Soc Nephrol. 2006;1:505–510
  24. Tsouchnikas I, Dounousi E, Papakonstantinou S, et al. Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients. Nephrology (Carlton). 2009;14:560–564
  25. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;
  26. Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2:89–99
  27. Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47:139–148
  28. Goodkin DA, Bragg-Gresham JL, Koenig KG, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270–3277
  29. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199–207
  30. Combe C, Albert JM, Bragg-Gresham JL, et al. The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2009;54:680–692
  31. den Elzen WP, van Manen JG, Boeschoten EW, Krediet RT, Dekker FW. The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis. Nephrol Dial Transplant. 2006;21:1588–1595
  32. Goldwasser P, Mittman N, Antignani A, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol. 1993;3:1613–1622
  33. Weinhandl ED, Rao M, Gilbertson DT, Collins AJ, Pereira BJ. Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003. Am J Kidney Dis. 2007;50:803–812
  34. Feldman HI, Joffe M, Robinson B, et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol. 2004;15:1623–1632
  35. Kausz AT, Solid C, Pereira BJ, Collins AJ, St Peter W. Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?. Am J Kidney Dis. 2005;45:136–147
  36. Spiegel DM, Khan I, Krishnan M, Mayne TJ. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008. Am J Kidney Dis. 2010;55:113–120

 Originally published online September 1, 2010.

PII: S0272-6386(10)01075-9

doi: 10.1053/j.ajkd.2010.06.013

American Journal of Kidney Diseases
Volume 57, Issue 2 , Pages 255-265 , February 2011

Article Tools

* Image Usage & Resolution